MLABMesa Laboratories, Inc.
Is the price fair?
Neither cheap nor expensive: nothing decisive, though at the top of its own P/E range.
Priced for ~1% a year FCF growth. Roughly in line with its three-year revenue growth of 4% a year.
Expensive vs its own history: P/E 151.2 vs a 77.7 median over 15 quarters (+95% vs median).
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What MLAB's price assumes
Mesa Laboratories, Inc. trades at 151× earnings against 35.5× for the median Scientific & Technical Instruments name, more expensive than its own group.
Trailing P/E · Scientific & Technical Instruments median 35.5 · 4.26× the median: the market pays up for this one
- Price / sales
- 2.30
Price / sales · as of 2026-Q2
- Free cash flow yield
- 7.3%
Free cash flow yield · Scientific & Technical Instruments median 3.9%
- Growth the price implies
- +0.52%
Growth the price implies · The price pays for +0.52% free cash flow growth a year for a decade; the business has delivered +14% a year over the last three.
Details›
- Price / bookas of 2026-Q2
- 3.04
- EV / EBITas of 2026-Q2
- 27.4
- EV / salesas of 2026-Q2
- 2.46
- Technology median P/E450 names
- 34.1
- Scientific & Technical Instruments median P/E17 names
- 35.5
- Free cash flow, trailing twelve months
- $53M
- Market capitalisation5.6 million shares, counted Aug 3, 2026
- $719M
- 3-year revenue growth
- +4.4%
- 3-year free cash flow growth
- +14%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $39.30 |
| Its own P/E history, median | $66.01 |
| Its own P/E history, upper quartile | $102.22 |
| 52-week range | $70.23 – $142.52 |
| Today | $128.51 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
What is it worth?
Today's price against what its own multiples, its cash flow and your growth assumption say it is worth.
Against its own past
Its multiples now against their own history, and how much of the price move came from earnings rather than the multiple.
Scientific & Technical Instruments
Ranks #11 of 11 by RyuScore